Anthony Cerami, PhD
Dr. Anthony Cerami is the founder of Araim Pharmaceuticals and board member since 2006.
Dr. Cerami has had a successful career applying detailed biochemical insights into understanding the pathogenesis of disease, and translating these discoveries into novel therapeutic products which have wide clinical utility.
He received his PhD from the Rockefeller University and completed a postdoctoral fellowship at Harvard Medical School, and has received three honorary Doctorates. Dr. Cerami was the Dean of Graduate and Post Graduate Studies at Rockefeller University. He established what is now the Feinstein Institute for Medical Research.
Dr. Cerami is the recipient of a number of prestigious awards, including the Luft Award in Diabetes and the Banting Medal for Scientific Achievement, awarded by the American Diabetes Association in recognition of his lifelong work on diabetes. He is a member of the National Academy of Sciences, Fellow of the American Academy of Arts and Sciences and Member of the Institute of Medicine of the National Academy of Sciences. He is also an Honorary Member of the American Society for Clinical Investigation and Fellow of the American Academy of Microbiology.
Dr. Cerami has been the inventor or co-inventor of over 150 issued U.S. patents and hundreds of foreign counterparts, including the anti-TNF monoclonal antibody that has been approved by the FDA for the treatment of Chron’s disease and Rheumatoid arthritis. Dr. Cerami is also the inventor of the hemoglobin A1c test that is used by diabetics worldwide. He is the author or co-author of over 500 scientific publications.